부산대학교 도서관

Objective: To provide a list of evidence-based psychopharmacology and psychotherapy treatments for child psychiatry. Method: Published reviews and Medline searches were examined to generate a list of treatments supported by randomized controlled trials. Results: For psychopharmacology, the best evidence to date supports the use of stimulant medications for attention-deficit/hyperactivity disorder and selective serotonin reuptake inhibitors (SSRIs) for obsessivecompulsive disorder. There is also reasonable evidence addressing SSRIs for anxiety disorders and moderate to severe major depressive disorder, and risperidone for autism. The psychosocial interventions best supported by well-designed studies are cognitive-behavioral and behavioral interventions, especially for mood, anxiety, and behavioral disorders. Family-based and systems of care interventions also have been found effective. Conclusions: Although the number of evidence-based treatments for child psychiatry is growing, much of clinical practice remains based on the adult literature and traditional models of care. Challenges toward adopting evidence-based practices are discussed. J. Am. Acad. Child Adolesc. Psychiatry, 2003;42(12):1388-1400. Key Words: evidence-based medicine, pharmacology, psychotherapy, children, adolescents.